Literature DB >> 23303664

Curcumin and neurodegenerative diseases.

Adriana Monroy1, Gordon J Lithgow, Silvestre Alavez.   

Abstract

Over the last 10 years curcumin has been reported to be effective against a wide variety of diseases and is characterized as having anticarcinogenic, hepatoprotective, thrombosuppressive, cardioprotective, antiarthritic, and anti-infectious properties. Recent studies performed in both vertebrate and invertebrate models have been conducted to determine whether curcumin was also neuroprotective. The efficacy of curcumin in several preclinical trials for neurodegenerative diseases has created considerable excitement mainly because of its lack of toxicity and low cost. This suggests that curcumin could be a worthy candidate for nutraceutical intervention. As aging is a common risk factor for neurodegenerative diseases, it is possible that some compounds that target aging mechanisms could also prevent these kinds of diseases. One potential mechanism to explain several of the general health benefits associated with curcumin is that it may prevent aging-associated changes in cellular proteins that lead to protein insolubility and aggregation. This loss in protein homeostasis is associated with several age-related diseases. Recently, curcumin has been found to help maintain protein homeostasis and extend lifespan in the model invertebrate Caenorhabditis elegans. Here, we review the evidence from several animal models that curcumin improves healthspan by preventing or delaying the onset of various neurodegenerative diseases.
Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303664      PMCID: PMC3578106          DOI: 10.1002/biof.1063

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  140 in total

Review 1.  Curcumin and neurodegenerative diseases: a perspective.

Authors:  Altaf S Darvesh; Richard T Carroll; Anupam Bishayee; Nicholas A Novotny; Werner J Geldenhuys; Cornelis J Van der Schyf
Journal:  Expert Opin Investig Drugs       Date:  2012-06-06       Impact factor: 6.206

Review 2.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

3.  Trehalose extends longevity in the nematode Caenorhabditis elegans.

Authors:  Yoko Honda; Masashi Tanaka; Shuji Honda
Journal:  Aging Cell       Date:  2010-05-06       Impact factor: 9.304

Review 4.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

5.  Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice.

Authors:  Randy Strong; Richard A Miller; Clinton M Astle; Joseph A Baur; Rafael de Cabo; Elizabeth Fernandez; Wen Guo; Martin Javors; James L Kirkland; James F Nelson; David A Sinclair; Bruce Teter; David Williams; Nurulain Zaveri; Nancy L Nadon; David E Harrison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

6.  The protective effect of curcumin on Aβ induced aberrant cell cycle reentry on primary cultured rat cortical neurons.

Authors:  J Wang; Y J Zhang; S Du
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-04       Impact factor: 3.507

7.  Optimized turmeric extracts have potent anti-amyloidogenic effects.

Authors:  R Douglas Shytle; Paula C Bickford; Kavon Rezai-zadeh; L Hou; Jin Zeng; Jun Tan; Paul R Sanberg; Cyndy D Sanberg; Bill Roschek; Ryan C Fink; Randall S Alberte
Journal:  Curr Alzheimer Res       Date:  2009-12       Impact factor: 3.498

8.  High-throughput screen for novel antimicrobials using a whole animal infection model.

Authors:  Terence I Moy; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Ralph Mazitschek; Gabriele Casadei; Kim Lewis; Anne E Carpenter; Frederick M Ausubel
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

9.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Authors:  Brian C Kraemer; Bin Zhang; James B Leverenz; James H Thomas; John Q Trojanowski; Gerard D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

10.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

View more
  32 in total

1.  Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.

Authors:  Jeyapriya Raja Sundaram; Charlene Priscilla Poore; Noor Hazim Bin Sulaimee; Tej Pareek; Wei Fun Cheong; Markus R Wenk; Harish C Pant; Sally A Frautschy; Chian-Ming Low; Sashi Kesavapany
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.

Authors:  L V Darbinyan; L E Hambardzumyan; K V Simonyan; V A Chavushyan; L P Manukyan; S A Badalyan; N Khalaji; V H Sarkisian
Journal:  Metab Brain Dis       Date:  2017-07-10       Impact factor: 3.584

3.  Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial.

Authors:  Mona Ahmadi; Elmira Agah; Shahriar Nafissi; Mahmoud Reza Jaafari; Mohammad Hossein Harirchian; Payam Sarraf; Sara Faghihi-Kashani; Seyed Jalal Hosseini; Abdolreza Ghoreishi; Vajiheh Aghamollaii; Mostafa Hosseini; Abbas Tafakhori
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 4.  Protective Effects of Curcumin in the Reproductive System: Anti-toxic, Semen Cryopreservative, and Contraceptive Actions.

Authors:  Maryam Matbou Riahi; Behzad Behnam; Neil C Henney; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Management of altered metabolic activity in Drosophila model of Huntington's disease by curcumin.

Authors:  Kumari Aditi; Akanksha Singh; Mallikarjun N Shakarad; Namita Agrawal
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-07

Review 6.  Therapeutic potential of curcumin for multiple sclerosis.

Authors:  Munibah Qureshi; Ebtesam A Al-Suhaimi; Fazli Wahid; Omer Shehzad; Adeeb Shehzad
Journal:  Neurol Sci       Date:  2017-10-27       Impact factor: 3.307

7.  Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

Authors:  Terry Golombick; Terrence H Diamond; Arumugam Manoharan; Rajeev Ramakrishna
Journal:  Case Rep Hematol       Date:  2015-06-25

8.  Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro.

Authors:  Ali Mohammadi Karakani; Gholamhossein Riazi; Seyed Mahmood Ghaffari; Shahin Ahmadian; Farzad Mokhtari; Mahshad Jalili Firuzi; Seyedeh Zahra Bathaie
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

Review 9.  Age-Related Alterations at Neuromuscular Junction: Role of Oxidative Stress and Epigenetic Modifications.

Authors:  Gabriella Dobrowolny; Alessandra Barbiera; Gigliola Sica; Bianca Maria Scicchitano
Journal:  Cells       Date:  2021-05-24       Impact factor: 6.600

10.  Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease.

Authors:  Dirk B Epplen; Thomas Prukop; Tobias Nientiedt; Philipp Albrecht; Friederike A Arlt; Ruth M Stassart; Celia M Kassmann; Axel Methner; Klaus-Armin Nave; Hauke B Werner; Michael W Sereda
Journal:  Ann Clin Transl Neurol       Date:  2015-06-24       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.